304 related articles for article (PubMed ID: 29025601)
41. Eosinophilia with FIP1L1-PDGFRA fusion in a patient with chronic myelomonocytic leukemia.
Zota V; Miron PM; Woda BA; Raza A; Wang SA
J Clin Oncol; 2008 Apr; 26(12):2040-1. PubMed ID: 18421057
[No Abstract] [Full Text] [Related]
42. A diagnostically difficult case of chronic myeloid neoplasm with eosinophilia and abnormalities of PDGFRA effectively treated with imatinib in accelerated phase: case report.
Rodzaj M; Gałazka K; Majewski M; Zduńczyk A
Pol Arch Med Wewn; 2009 Dec; 119(12):838-41. PubMed ID: 20010473
[TBL] [Abstract][Full Text] [Related]
43. BCR-PDGFRA fusion in a T lymphoblastic leukemia/lymphoma.
Yigit N; Wu WW; Subramaniyam S; Mathew S; Geyer JT
Cancer Genet; 2015; 208(7-8):404-7. PubMed ID: 26095243
[TBL] [Abstract][Full Text] [Related]
44. Myocarditis, kidney injury, and hypereosinophilia: FIP1L1-PDGFRA-positive myeloid/lymphoid neoplasm with eosinophilia.
Reid SE; Patel SA
Blood; 2021 Sep; 138(12):1086. PubMed ID: 34554219
[No Abstract] [Full Text] [Related]
45. Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohort.
Metzgeroth G; Steiner L; Naumann N; Lübke J; Kreil S; Fabarius A; Haferlach C; Haferlach T; Hofmann WK; Cross NCP; Schwaab J; Reiter A
Leukemia; 2023 Sep; 37(9):1860-1867. PubMed ID: 37454239
[TBL] [Abstract][Full Text] [Related]
46. Molecular analysis of PDGFRalpha/beta genes in core binding factor leukemia with eosinophilia.
Monma F; Nishii K; Lorenzo F; Usui E; Ueda Y; Watanabe Y; Kawakami K; Oka K; Mitani H; Sekine T; Tamaki S; Mizutani M; Yagasaki F; Doki N; Miyawaki S; Katayama N; Shiku H
Eur J Haematol; 2006 Jan; 76(1):18-22. PubMed ID: 16343267
[TBL] [Abstract][Full Text] [Related]
47. The severity of FIP1L1-PDGFRA-positive chronic eosinophilic leukaemia is associated with polymorphic variation at the IL5RA locus.
Burgstaller S; Kreil S; Waghorn K; Metzgeroth G; Preudhomme C; Zoi K; White H; Cilloni D; Zoi C; Brito-Babapulle F; Walz C; Reiter A; Cross NC
Leukemia; 2007 Dec; 21(12):2428-32. PubMed ID: 17914408
[TBL] [Abstract][Full Text] [Related]
48. Transient macular erythema with eosinophilia in a patient carrying the FIP1L1-PDGFRA fusion gene.
Yahara H; Satoh T; Hashimoto T; Yokozeki H
Br J Dermatol; 2007 Dec; 157(6):1284-7. PubMed ID: 17916194
[No Abstract] [Full Text] [Related]
49. F604S exchange in FIP1L1-PDGFRA enhances FIP1L1-PDGFRA protein stability via SHP-2 and SRC: a novel mode of kinase inhibitor resistance.
Gorantla SP; Zirlik K; Reiter A; Yu C; Illert AL; Von Bubnoff N; Duyster J
Leukemia; 2015 Aug; 29(8):1763-70. PubMed ID: 25761934
[TBL] [Abstract][Full Text] [Related]
50. Chronic eosinophilic leukaemia with FIP1L1-PDGFRA fusion and T6741 mutation that evolved from Langerhans cell histiocytosis with eosinophilia after chemotherapy.
Ohnishi H; Kandabashi K; Maeda Y; Kawamura M; Watanabe T
Br J Haematol; 2006 Sep; 134(5):547-9. PubMed ID: 16856885
[No Abstract] [Full Text] [Related]
51. Utilizing next-generation sequencing to characterize a case of acute myeloid leukemia with t(4;12)(q12;p13) in the absence of ETV6/CHIC2 and ETV6/PDGFRA gene fusions.
Koleilat A; McGarrah PW; Olteanu H; Van Dyke DL; Smadbeck JB; Johnson SH; Vasmatzis G; Hoppman NL; Xu X; Ketterling RP; Greipp PT; Baughn LB; Patnaik MS; Peterson JF
Cancer Genet; 2022 Jan; 260-261():1-5. PubMed ID: 34781094
[TBL] [Abstract][Full Text] [Related]
52. Osteolytic lesion as initial presentation in FIP1L1-PDGFRA-rearranged myeloid/lymphoid neoplasm with eosinophilia: a case report.
Lv Y; Yao X; Ling Q; Suo S; Wang J; Zhao S; Gao X; Tong H; Jin J; Zhang X; Yu W
Ann Hematol; 2024 Jan; 103(1):357-360. PubMed ID: 37777636
[No Abstract] [Full Text] [Related]
53. Myeloid neoplasm with eosinophilia associated with isolated extramedullary FIP1L1/PDGFRA rearrangement.
Hilal T; Fauble V; Ketterling RP; Kelemen K
Cancer Genet; 2018 Jan; 220():13-18. PubMed ID: 29310833
[TBL] [Abstract][Full Text] [Related]
54. Myeloid neoplasms with eosinophilia.
Reiter A; Gotlib J
Blood; 2017 Feb; 129(6):704-714. PubMed ID: 28028030
[TBL] [Abstract][Full Text] [Related]
55. Next generation sequencing of myeloid neoplasms with eosinophilia harboring the FIP1L1-PDGFRA mutation.
Pardanani A; Lasho T; Barraco D; Patnaik M; Elala Y; Tefferi A
Am J Hematol; 2016 Mar; 91(3):E10-1. PubMed ID: 26663400
[No Abstract] [Full Text] [Related]
56. Validation of a new three-color fluorescence in situ hybridization (FISH) method to detect CHIC2 deletion, FIP1L1/PDGFRA fusion and PDGFRA translocations.
Fink SR; Belongie KJ; Paternoster SF; Smoley SA; Pardanani AD; Tefferi A; Van Dyke DL; Ketterling RP
Leuk Res; 2009 Jun; 33(6):843-6. PubMed ID: 19118897
[TBL] [Abstract][Full Text] [Related]
57. The FIP1L1-PDGFRA fusion gene and the KIT D816V mutation are coexisting in a small subset of myeloid/lymphoid neoplasms with eosinophilia.
Schmitt-Graeff AH; Erben P; Schwaab J; Vollmer-Kary B; Metzgeroth G; Sotlar K; Horny HP; Kreipe HH; Fisch P; Reiter A
Blood; 2014 Jan; 123(4):595-7. PubMed ID: 24458279
[No Abstract] [Full Text] [Related]
58. [Identification of FIP1L1-PDGFRA fusion, and expression of signal transducer and activator of transcription 5 in hypereosinophilic syndrome].
Zhang GS; Li B; Pei MF; Dai CW; Zheng WL; Shen JK
Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(18):1541-4. PubMed ID: 15500716
[TBL] [Abstract][Full Text] [Related]
59. A case of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia with a rare FIP1L1 breakpoint.
Lambert F; Heimann P; Herens C; Chariot A; Bours V
J Mol Diagn; 2007 Jul; 9(3):414-9. PubMed ID: 17591942
[TBL] [Abstract][Full Text] [Related]
60. Identification and characterization of novel oncogenes in chronic eosinophilic leukemia and T-cell acute lymphoblastic leukemia.
Cools J
Verh K Acad Geneeskd Belg; 2010; 72(1-2):55-70. PubMed ID: 20726440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]